Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives

被引:68
作者
Galal, Shadia A. [1 ]
Abdelsamie, Ahmed S. [1 ]
Tokuda, Harukuni [2 ]
Suzuki, Nobutaka [2 ]
Lida, Akira [3 ]
ElHefnawi, Mahmoud M. [4 ]
Ramadan, Raghda A. [4 ]
Atta, Mona H. E. [4 ]
El Diwani, Hoda I. [1 ]
机构
[1] Natl Res Ctr, Div Pharmaceut & Drug Ind, Dept Chem Nat & Microbial Prod, Cairo 12622, Egypt
[2] Kanazawa Univ, Grad Sch Med Sci, Clin R&D, Dept Complementary & Alternat Med, Kanazawa, Ishikawa 9208640, Japan
[3] Kinki Univ, Fac Agr, Nara 6318505, Japan
[4] Natl Res Ctr, Ctr Excellence Adv Sci, Biomed Informat & Chemoinformat Grp, Cairo 12622, Egypt
关键词
Synthesis; Quinoxalines; Anti-tumor promoter; Epstein-Barr virus; Two-stage carcinogenesis; 12-O-Tetradecanoylphorbol-13-acetate (TPA); Docking; Protein tyrosine kinase receptor (PTK); BIOLOGICAL EVALUATION; ANTITUMOR AGENT; ETHYL CARBOETHOXYFORMIMIDATE; ACID XK469; INHIBITORS; CELLS; ACTIVATION; COMPLEXES; RECEPTOR; ANALOGS;
D O I
10.1016/j.ejmech.2010.11.022
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The reaction of o-phenylene diamine and ethyl oxamate is reinvestigated and led to 3-aminoquinoxalin-2-(1H)-one rather than benzimidazole-2-carboxamide as was previously reported. The structure of the obtained quinoxaline has been confirmed by X-ray. The anti-tumor activity of synthesized quinoxalines 1-21 has been evaluated by studying their possible inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Among the studied compounds 1-21, compounds 12, 8, 13, 18, 17 and 19, respectively, demonstrated strong inhibitory effects on the EBV-EA activation without showing any cytotoxicity and their effects being stronger than that of a representative control, oleanolic acid. Furthermore, compound 12 exhibited a remarkable inhibitory effect on skin tumor promotion in an in vivo two-stage mouse skin carcinogenesis test using 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter. The result of the present investigation indicated that compound 12 might be valuable as a potent cancer chemopreventive agent. Moreover, the molecular docking into PTK (PDB: 1t46) has been done for lead optimization of the aforementioned compounds as potential PTK inhibitors. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:327 / 340
页数:14
相关论文
共 40 条
[11]   Part 3: Synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)-oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)-oxy]phenoxy}propionic acid [J].
Hazeldine, ST ;
Polin, L ;
Kushner, J ;
White, K ;
Corbett, TH ;
Biehl, J ;
Horwitz, JP .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) :1069-1081
[12]   II. Synthesis and biological evaluation of some bioisosteres and congeners of the antitumor agent, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid (XK469) [J].
Hazeldine, ST ;
Polin, L ;
Kushner, J ;
White, K ;
Bouregeois, NM ;
Crantz, B ;
Palomino, E ;
Corbett, TH ;
Horwitz, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) :3130-3137
[13]  
HORWITZ JP, 2003, Patent No. 03011832
[14]  
HU Y, 2006, Patent No. 1951923
[15]  
Hu Y., 2006, Faming Zhuanli Shenqing Gongkai Shuomingshu, Patent No. [CN 1,951,923, 10,154,536, 10154536]
[16]   COMBINED EFFECT OF THE EXTRACTS FROM CROTON-TIGLIUM, EUPHORBIA-LATHYRIS OR EUPHORBIA-TIRUCALLI AND NORMAL-BUTYRATE ON EPSTEIN-BARR VIRUS EXPRESSION IN HUMAN-LYMPHOBLASTOID P3HR-1 AND RAJI CELLS [J].
ITO, Y ;
KAWANISHI, M ;
HARAYAMA, T ;
TAKABAYASHI, S .
CANCER LETTERS, 1981, 12 (03) :175-180
[17]   Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma [J].
Khier, Sonia ;
Deleulze-Masquefa, Carine ;
Moarbess, Georges ;
Gattacceca, Florence ;
Margout, Delphine ;
Solassol, Isabelle ;
Cooper, Jean-Francois ;
Pinguet, Frederic ;
Bonnet, Pierre-Antoine ;
Bressolle, Francoise M. M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 39 (1-3) :23-29
[18]   The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) provokes a prolonged morphologic response and ERK activation in Tsc2-null renal tumor cells [J].
Kolb, TM ;
Davis, MA .
TOXICOLOGICAL SCIENCES, 2004, 81 (01) :233-242
[19]   STUDIES ON INHIBITORS OF SKIN-TUMOR PROMOTION .1. INHIBITORY EFFECTS OF TRITERPENES FROM EUPTELEA-POLYANDRA ON EPSTEIN-BARR VIRUS-ACTIVATION [J].
KONOSHIMA, T ;
TAKASAKI, M ;
KOZUKA, M ;
TOKUDA, H .
JOURNAL OF NATURAL PRODUCTS, 1987, 50 (06) :1167-1170
[20]  
Lennartson J, 2005, CANC THER, V3, P5